Chronic fatigue syndrome - An update

被引:35
作者
Shephard, RJ
机构
[1] Def & Civil Inst Environm Med, Toronto, ON M3M 3B9, Canada
[2] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada
关键词
D O I
10.2165/00007256-200131030-00003
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The chronic fatigue syndrome is characterised by a fatigue that is disproportionate to the intensity of effort that is undertaken, has persisted for 6 months or longer and has no obvious cause. Unless there has been a long period of patient or physician- imposed inactivity, objective data may show little reduction in muscle strength or peak aerobic power, but the affected individual avoids heavy activity. The study of aetiology and treatment has been hampered by the low disease prevalence (probably <0.1% of the general population), and (until recently) by a lack of clear and standardised diagnostic criteria. It is unclear how far the aetiology is similar for athletes and nonathletes. It appears that in top competitors, overtraining and/or a negative energy balance can be precipitating factors. A wide variety of other possible causes and/or precipitating factors have been cited in the general population, including psychological stress, disorders of personality and affect, dysfunction of the hypothalamic-pituitary-adrenal axis, hormonal imbalance, nutritional deficits, immune suppression or activation and chronic infection. However, none of these factors have been observed consistently. The prognosis is poor; often disability and impairment of athletic performance are prolonged. Prevention of overtraining by careful monitoring seems the most effective approach in athletes. In those where the condition is established, treatment should aim at breaking the vicious cycle of effort avoidance, deterioration in physical condition and an increase in fatigue through a combination of encouragement and a progressive exercise programme.
引用
收藏
页码:167 / 194
页数:28
相关论文
共 294 条
  • [1] HORMONAL CHANGES IN SERUM IN YOUNG MEN DURING PROLONGED PHYSICAL STRAIN
    AAKVAAG, A
    SAND, T
    OPSTAD, PK
    FONNUM, F
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1978, 39 (04): : 283 - 291
  • [2] Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder
    Aaron, LA
    Burke, MM
    Buchwald, D
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (02) : 221 - 227
  • [3] ABBEY SE, 1991, REV INFECT DIS, V13, pS73
  • [4] Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-Binding protein-1 in chronic fatigue syndrome
    Allain, TJ
    Bearn, JA
    Coskeran, P
    Jones, J
    Checkley, A
    Butler, J
    Wessely, S
    Miell, JP
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 41 (05) : 567 - 573
  • [5] [Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
  • [6] Arpino C, 1999, Ann Ist Super Sanita, V35, P435
  • [7] Post-infection fatigue syndrome following Q fever
    Ayres, JG
    Flint, N
    Smith, EG
    Tunnicliffe, WS
    Fletcher, TJ
    Hammond, K
    Ward, D
    Marmion, BP
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02): : 105 - 123
  • [8] Recovery from infectious mononucleosis after altitude training in an elite middle distance runner
    Bailey, DM
    Davies, B
    Budgett, R
    Gandy, G
    [J]. BRITISH JOURNAL OF SPORTS MEDICINE, 1997, 31 (02) : 153 - 154
  • [9] BARKER E, 1994, INFECT DIS S1, V18, pS136
  • [10] Bazelmans E, 1997, Ned Tijdschr Geneeskd, V141, P1520